Immunomodulatory lipid mediator profiling of cerebrospinal fluid following surgery in older adults

Abstract Arachidonic acid (AA), docosahexaenoic acid (DHA), and eicosapentaenoic acid (EPA) derived lipids play key roles in initiating and resolving inflammation. Neuro-inflammation is thought to play a causal role in perioperative neurocognitive disorders, yet the role of these lipids in the human...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Niccolò Terrando, John J. Park, Michael Devinney, Cliburn Chan, Mary Cooter, Pallavi Avasarala, Joseph P. Mathew, Quintin J. Quinones, Krishna Rao Maddipati, Miles Berger, for the MADCO-PC Study Team
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/4c6cc38806d44862bca6b02bf708d86d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4c6cc38806d44862bca6b02bf708d86d
record_format dspace
spelling oai:doaj.org-article:4c6cc38806d44862bca6b02bf708d86d2021-12-02T10:44:08ZImmunomodulatory lipid mediator profiling of cerebrospinal fluid following surgery in older adults10.1038/s41598-021-82606-52045-2322https://doaj.org/article/4c6cc38806d44862bca6b02bf708d86d2021-02-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-82606-5https://doaj.org/toc/2045-2322Abstract Arachidonic acid (AA), docosahexaenoic acid (DHA), and eicosapentaenoic acid (EPA) derived lipids play key roles in initiating and resolving inflammation. Neuro-inflammation is thought to play a causal role in perioperative neurocognitive disorders, yet the role of these lipids in the human central nervous system in such disorders is unclear. Here we used liquid chromatography–mass spectrometry to quantify AA, DHA, and EPA derived lipid levels in non-centrifuged cerebrospinal fluid (CSF), centrifuged CSF pellets, and centrifuged CSF supernatants of older adults obtained before, 24 h and 6 weeks after surgery. GAGE analysis was used to determine AA, DHA and EPA metabolite pathway changes over time. Lipid mediators derived from AA, DHA and EPA were detected in all sample types. Postoperative lipid mediator changes were not significant in non-centrifuged CSF (p > 0.05 for all three pathways). The AA metabolite pathway showed significant changes in centrifuged CSF pellets and supernatants from before to 24 h after surgery (p = 0.0000247, p = 0.0155 respectively), from before to 6 weeks after surgery (p = 0.0000497, p = 0.0155, respectively), and from 24 h to 6 weeks after surgery (p = 0.0000499, p = 0.00363, respectively). These findings indicate that AA, DHA, and EPA derived lipids are detectable in human CSF, and the AA metabolite pathway shows postoperative changes in centrifuged CSF pellets and supernatants.Niccolò TerrandoJohn J. ParkMichael DevinneyCliburn ChanMary CooterPallavi AvasaralaJoseph P. MathewQuintin J. QuinonesKrishna Rao MaddipatiMiles Bergerfor the MADCO-PC Study TeamNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Niccolò Terrando
John J. Park
Michael Devinney
Cliburn Chan
Mary Cooter
Pallavi Avasarala
Joseph P. Mathew
Quintin J. Quinones
Krishna Rao Maddipati
Miles Berger
for the MADCO-PC Study Team
Immunomodulatory lipid mediator profiling of cerebrospinal fluid following surgery in older adults
description Abstract Arachidonic acid (AA), docosahexaenoic acid (DHA), and eicosapentaenoic acid (EPA) derived lipids play key roles in initiating and resolving inflammation. Neuro-inflammation is thought to play a causal role in perioperative neurocognitive disorders, yet the role of these lipids in the human central nervous system in such disorders is unclear. Here we used liquid chromatography–mass spectrometry to quantify AA, DHA, and EPA derived lipid levels in non-centrifuged cerebrospinal fluid (CSF), centrifuged CSF pellets, and centrifuged CSF supernatants of older adults obtained before, 24 h and 6 weeks after surgery. GAGE analysis was used to determine AA, DHA and EPA metabolite pathway changes over time. Lipid mediators derived from AA, DHA and EPA were detected in all sample types. Postoperative lipid mediator changes were not significant in non-centrifuged CSF (p > 0.05 for all three pathways). The AA metabolite pathway showed significant changes in centrifuged CSF pellets and supernatants from before to 24 h after surgery (p = 0.0000247, p = 0.0155 respectively), from before to 6 weeks after surgery (p = 0.0000497, p = 0.0155, respectively), and from 24 h to 6 weeks after surgery (p = 0.0000499, p = 0.00363, respectively). These findings indicate that AA, DHA, and EPA derived lipids are detectable in human CSF, and the AA metabolite pathway shows postoperative changes in centrifuged CSF pellets and supernatants.
format article
author Niccolò Terrando
John J. Park
Michael Devinney
Cliburn Chan
Mary Cooter
Pallavi Avasarala
Joseph P. Mathew
Quintin J. Quinones
Krishna Rao Maddipati
Miles Berger
for the MADCO-PC Study Team
author_facet Niccolò Terrando
John J. Park
Michael Devinney
Cliburn Chan
Mary Cooter
Pallavi Avasarala
Joseph P. Mathew
Quintin J. Quinones
Krishna Rao Maddipati
Miles Berger
for the MADCO-PC Study Team
author_sort Niccolò Terrando
title Immunomodulatory lipid mediator profiling of cerebrospinal fluid following surgery in older adults
title_short Immunomodulatory lipid mediator profiling of cerebrospinal fluid following surgery in older adults
title_full Immunomodulatory lipid mediator profiling of cerebrospinal fluid following surgery in older adults
title_fullStr Immunomodulatory lipid mediator profiling of cerebrospinal fluid following surgery in older adults
title_full_unstemmed Immunomodulatory lipid mediator profiling of cerebrospinal fluid following surgery in older adults
title_sort immunomodulatory lipid mediator profiling of cerebrospinal fluid following surgery in older adults
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/4c6cc38806d44862bca6b02bf708d86d
work_keys_str_mv AT niccoloterrando immunomodulatorylipidmediatorprofilingofcerebrospinalfluidfollowingsurgeryinolderadults
AT johnjpark immunomodulatorylipidmediatorprofilingofcerebrospinalfluidfollowingsurgeryinolderadults
AT michaeldevinney immunomodulatorylipidmediatorprofilingofcerebrospinalfluidfollowingsurgeryinolderadults
AT cliburnchan immunomodulatorylipidmediatorprofilingofcerebrospinalfluidfollowingsurgeryinolderadults
AT marycooter immunomodulatorylipidmediatorprofilingofcerebrospinalfluidfollowingsurgeryinolderadults
AT pallaviavasarala immunomodulatorylipidmediatorprofilingofcerebrospinalfluidfollowingsurgeryinolderadults
AT josephpmathew immunomodulatorylipidmediatorprofilingofcerebrospinalfluidfollowingsurgeryinolderadults
AT quintinjquinones immunomodulatorylipidmediatorprofilingofcerebrospinalfluidfollowingsurgeryinolderadults
AT krishnaraomaddipati immunomodulatorylipidmediatorprofilingofcerebrospinalfluidfollowingsurgeryinolderadults
AT milesberger immunomodulatorylipidmediatorprofilingofcerebrospinalfluidfollowingsurgeryinolderadults
AT forthemadcopcstudyteam immunomodulatorylipidmediatorprofilingofcerebrospinalfluidfollowingsurgeryinolderadults
_version_ 1718396824459411456